Prognostic variability among nonsmall cell lung cancer patients with pathologic N1 lymph node involvement
Open Access
Abstract
BACKGROUND.: Patients who have nonsmall cell lung cancer with N1 lymph node status are an intermediate group of patients who have a variable prognosis. Differences in lymph node level (hilar or pulmonary lymph nodes) may influence patient survival. The authors retrospectively analyzed the factors that influenced prognosis, including the level of N1 lymph node involvement.METHODS.: The authors used the Tuscan Cancer Registry archives to retrieve records on 2523 patients who had lung tumors diagnosed during the period from 1996 and 1998 in the provinces of Florence and Prato, central Italy. To analyze the survival of patients according to the level of lymph node involvement, the prognoses of patients with nonsmall cell lung cancer who had N1 lymph node status were compared in a population‐based case series. Among 112 patients with pathologic N1 status, the following variables were analyzed for their influence on postoperative survival: gender, age, cell type, pathologic tumor status, the number of metastatic lymph nodes, the level of metastatic lymph nodes (hilar or pulmonary), and the type of surgical resection.RESULTS.: The 5‐year survival rates for patients who had involvement of pulmonary and hilar lymph nodes were 41.2% and 21.8%, respectively (P= .005). A Cox proportional hazards model analysis indicated that the presence of hilar lymph node involvement was an independent prognostic factor.CONCLUSIONS.: N1 pathologic lymph node status was identified in a combination of subgroups with different prognoses, and the presence of hilar lymph node disease had prognostic significance. This difference in survival may lead to the use of different therapies for these subgroups of patients with pathologic N1 nonsmall cell lung cancer. Cancer 2006. © 2006 American Cancer Society.Keywords
This publication has 15 references indexed in Scilit:
- Border between N1 and N2 stations in lung carcinoma: Lessons from lymph node metastatic patterns of lower lobe tumorsThe Journal of Thoracic and Cardiovascular Surgery, 2005
- Prognostic significance of main bronchial lymph nodes involvement in non-small cell lung carcinoma: N1 or N2?Lung Cancer, 2004
- Prolonged survival in patients with resected non–small cell lung cancer and single-level N2 diseaseThe Journal of Thoracic and Cardiovascular Surgery, 2004
- Survival and characteristics of lymph node involvement in patients with N1 non-small cell lung cancerLung Cancer, 2004
- Independent predictive value of the overall number of metastatic N1 and N2 stations in lung cancerThe Japanese Journal of Thoracic and Cardiovascular Surgery, 2003
- Where is the boundary between N1 and N2 stations in lung cancer?The Annals of Thoracic Surgery, 2000
- Unfavorable Prognosis of Patients With Stage II Non-small Cell Lung Cancer Associated With Macroscopic Nodal MetastasesChest, 1999
- Prognostic significance of surgical-pathologic N1 disease in non-small cell carcinoma of the lungThe Annals of Thoracic Surgery, 1999
- Type of Lymph Node Involvement Influences Survival Rates in T1N1M0 Non-small Cell Lung CarcinomaChest, 1996
- Nonparametric Estimation from Incomplete ObservationsJournal of the American Statistical Association, 1958